RTW Investments
Venture capital
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
15Deep-tech portfolio6 active
9Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Evommune
62Co-investorsShare a portfolio company
Portfolio · 15 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Century Therapeutics | Biotech | Active | Mar 15, 2021 | $160.0M |
| Prelude Therapeutics | Biotech | Active | Aug 28, 2020 | $97.0M |
| Lyell Immunopharma | Biotech | Active | Mar 20, 2020 | $493.0M |
| Corxel | Biotech | Active | — | — |
| Jade Biosciences | Biotech | Active | — | — |
| Windward Bio | Biotech | Active | — | — |
| Evommune | Biotech | Public | Jan 8, 2025 | $267.3M |
| Aktis Oncology | Biotech | Public | Oct 2, 2024 | $175.0M |
| Avidity Biosciences | Biotech | Acquired | Mar 19, 2024 | $527.8M |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Immunocore | Biotech | Public | — | — |
| Kailera Therapeutics | Biotech | Public | — | — |
| Praxis Precision Medicine | Biotech | Public | — | — |
| Savara Pharma | Biotech | Public | — | — |
| Tempus AI | Medtech | Public | — | — |
Peer ranks
Portfolio size#28
Portfolio exits#13
Raises, 12 months#88
Co-investors#19
Co-investors
- RA CapitalVenture capital4 shared
- Third Rock VenturesVenture capital4 shared
- Deerfield Capital ManagementVenture capital3 shared
- GVVenture capital3 shared
- Perceptive AdvisorsVenture capital3 shared
- Bay City CapitalVenture capital2 shared
- Boxer CapitalVenture capital2 shared
- Cormorant Asset ManagementVenture capital2 shared
- EcoR1 CapitalVenture capital2 shared
- Foresite CapitalVenture capital2 shared
Sectors
- Biotech14
- Medtech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.